PlainRecalls
FDA Drug Moderate Class II Terminated

Aripiprazole Tablets, USP 15 mg tablets, packaged in a) 1000 count bottle, NDC 60505-2675-8; b) 30 count bottle, NDC 60505-2675-3; Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326

Reported: November 25, 2020 Initiated: November 11, 2020 #D-0106-2021

Product Description

Aripiprazole Tablets, USP 15 mg tablets, packaged in a) 1000 count bottle, NDC 60505-2675-8; b) 30 count bottle, NDC 60505-2675-3; Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326

Reason for Recall

Failed Dissolution Specifications: Out of specification for dissolution.

Details

Recalling Firm
Apotex Corp.
Units Affected
a)552 bottles; b) 3192 bottles
Distribution
Distributed Nationwide in the USA
Location
Weston, FL

Frequently Asked Questions

What product was recalled?
Aripiprazole Tablets, USP 15 mg tablets, packaged in a) 1000 count bottle, NDC 60505-2675-8; b) 30 count bottle, NDC 60505-2675-3; Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326. Recalled by Apotex Corp.. Units affected: a)552 bottles; b) 3192 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Out of specification for dissolution.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 25, 2020. Severity: Moderate. Recall number: D-0106-2021.